SurModics
SRDX
#6828
Rank
ยฃ0.46 B
Marketcap
ยฃ32.24
Share price
0.00%
Change (1 day)
2.75%
Change (1 year)
Categories

Revenue for SurModics (SRDX)

Revenue in 2025 (TTM): ยฃ91.95 Million

According to SurModics's latest financial reports the company's current revenue (TTM ) is ยฃ90.61 Million. In 2024 the company made a revenue of ยฃ99.96 Million a decrease over the revenue in the year 2023 that were of ยฃ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SurModics from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ91.95 M-8.01%
2024 ยฃ99.96 M-7.85%
2023 ยฃ0.10 B28.82%
2022 ยฃ84.21 M7.4%
2021 ยฃ78.41 M13.05%
2020 ยฃ69.36 M-9.45%
2019 ยฃ76.6 M12.33%
2018 ยฃ68.19 M27.36%
2017 ยฃ53.54 M-8.98%
2016 ยฃ58.82 M35.72%
2015 ยฃ43.34 M16.83%
2014 ยฃ37.09 M8.96%
2013 ยฃ34.04 M2.17%
2012 ยฃ33.32 M-6.51%
2011 ยฃ35.64 M-15.4%
2010 ยฃ42.13 M-9.94%
2009 ยฃ46.77 M-49.75%
2008 ยฃ93.09 M130.45%
2007 ยฃ40.39 M12.78%
2006 ยฃ35.81 M-4.65%
2005 ยฃ37.56 M39.44%
2004 ยฃ26.94 M1.94%
2003 ยฃ26.42 M34.61%
2002 ยฃ19.63 M18.4%
2001 ยฃ16.58 M30.51%
2000 ยฃ12.7 M36.92%
1999 ยฃ9.27 M46.94%
1998 ยฃ6.31 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nektar Therapeutics
NKTR
ยฃ46.95 M-48.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.80 B 36,104.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ20.6 M-77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
ยฃ1.14 B 1,159.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
ยฃ69.11 B 76,181.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.88 B 36,193.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
ยฃ5.09 B 5,519.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
ยฃ0.11 B 28.39%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ2.51 B 2,679.32%๐Ÿ‡บ๐Ÿ‡ธ USA